Biopharma's stock market winners of 2022 revealed

Pipeline performers including Lilly, Daiichi and Sarepta topped the stock market gainers last year, as the Covid trade was thoroughly unwound.

Biopharma Y-mAbs Stokes Investor Excitement With Latest Results

Few biopharma risers stand out at the half year

Evaluate Search

Madrigal Pharmaceuticals

Cytel's Solara wins 2022 Fierce Innovation Award

Biotech Stocks Notch A Blazing Path In 2022 — Why The Good Times

Rubius Therapeutics

Top 20 BioPharma Companies based on 2022 Total Revenue

New Clarivate Biopharma Dealmaking Report Reveals Investment